Abstract: Compounds and a method for imaging myocardial perfusion, including administering to a patient a compound linked to an imaging moiety, wherein the compound binds MC-1, and scanning the patient using diagnostic imaging. Kits including the compound or precursor compounds linked or not linked to an imaging moiety are also described.
Abstract: Compounds and a method for imaging myocardial perfusion, including administering to a patient a compound linked to an imaging moiety, wherein the compound binds MC-1, and scanning the patient using diagnostic imaging. Kits including the compound or precursor compounds linked or not linked to an imaging moiety are also described.
Abstract: Compounds and a method for imaging myocardial perfusion, including administering to a patient a compound linked to an imaging moiety, wherein the compound binds MC-1, and scanning the patient using diagnostic imaging. Kits including the compound or precursor compounds linked or not linked to an imaging moiety are also described.
Abstract: The invention relates to novel compounds having the general formula (I), and which compounds are useful to manufacture a medicament to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma, and vasoconstriction, e.g. hypertension.
Type:
Grant
Filed:
July 10, 2008
Date of Patent:
November 27, 2012
Assignee:
Respiratorius AB
Inventors:
Maria Dalence, Martin Johansson, Viveca Thornqvist Oltner, Jörgen Toftered, David Wensbo
Abstract: The invention relates to novel compounds having the general formula (I), and which compounds are useful to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma.
Type:
Application
Filed:
February 24, 2010
Publication date:
February 16, 2012
Applicant:
RESPIRATORIUS AB
Inventors:
Martin Johansson, Viveca Thornqvist Otlner, Jorgen Toftered, David Wensbo, Maria Dalence
Abstract: The present invention discloses a device and an optical liquid sensor for drug screening, and a method for using these. More particularly a device, an optical liquid sensor, and a method, for repeatable measurements of the effect of a test drug on a biological tissue sample are described.